Synonym(s)
butcher's broom; butcher's broom rhizoma; butcher's broom root; rusci aculeati rhizoma; ruscus aculeatus; Ruscus aculeatus L
DefinitionThis section has been translated automatically.
Butcher's broom extract contains a mixture of different steroid saponins as the main active substance (such as the spirostanol saponins ruscin, ruscuside, aglyka, ruscogenin) and is systemically used for the treatment of lower leg edema in the context of chronic venous insufficiency. Ruscogenin is in use as hemorrhoidal therapeutic agent.
see under Rusci aculeati rhizoma
Pharmacodynamics (Effect)This section has been translated automatically.
In naturopathy it is known as stimulating blood circulation, anti-inflammatory, slightly diuretic and vitalizing. In a randomized, placebo-controlled double-blind study with 166 patients with chronic venous insufficiency, superiority over placebo was demonstrated.
You might also be interested in
IndicationThis section has been translated automatically.
Dosage and method of useThis section has been translated automatically.
2 times/day 30-50 mg p.o.
PreparationsThis section has been translated automatically.
Duoform novo, Fagorutin Ruscus, Phlebodril mono, Venelbin ruscus FT
Note(s)This section has been translated automatically.
The steroid sapogenins ruscogenin and neoruscogenin are found in the roots of the butcher's broom.
LiteratureThis section has been translated automatically.
- Allaert FA (2016) Combination of Ruscus aculeatus extract, hesperidin methylchalcone and ascorbic acid: a comprehensive review of their pharmacological and clinical effects and of the pathophysiology of chronic venous disease. Int Angiol 35:111-116.
- Reuter J, Wölfle U, Korting HC, Schempp C (2010) Which plant for which skin disease? Part 2: Dermatophytes, chronic venous insufficiency, photoprotection, actinic keratoses, vitiligo, hair loss, cosmetic indications. J Dtsch Dermatol Ges. 8: 866-873
- Vanscheidt W et al (2002) Efficacy and safety of a butcher`s broom preparation compared to placebo in patients suffering from chronic venous insufficiency. Drug research 52: 243-250